Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo

This publication has 27 references indexed in Scilit:

• Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use
  Tropical Medicine & International Health, 2005
• Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana
  Tropical Medicine & International Health, 2005
• Intermittent Presumptive Treatment for Malaria
  PLoS Medicine, 2005
• Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine–pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria
  Infection, Genetics and Evolution, 2004
• Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment ofPlasmodium falciparumMalaria
  The Journal of Infectious Diseases, 2002
• Gametocytaemia in senegalese children with uncomplicatedFalciparummalaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
  Parasite, 2001
• Sequence Variations in the Genes Encoding Dihydropteroate Synthase and Dihydrofolate Reductase and Clinical Response to Sulfadoxine‐Pyrimethamine in Patients with Acute Uncomplicated Falciparum Malaria
  The Journal of Infectious Diseases, 2000
• Molecular assays for surveillance of antifolate-resistant malaria
  The Lancet, 1998
• Unexpected trend in chemosensitivity of Plasmodium falciparum in Brazzaville, Congo
  The Lancet, 1991
• Malaria and urbanization in Central Africa: the example of Brazzaville
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1987